Prognostic value and anti-tumor immunity role of TMED9 in pan-cancer: a bioinformatics study
<i>TMED9</i> serves as a novel "cancer indicator" and "clinical prognostic marker", capable of reshaping the TME, impacting the immunotherapeutic response, and guiding precise treatments for cancers to a certain extent.
Authors
- Pengyu Tan
- Wenjian Ma (ORCID: https://orcid.org/0000-0002-3392-1549)
- Sa Zhou (ORCID: https://orcid.org/0000-0002-3983-0533)
- Yichi Liu
- Haodi Wang (ORCID: https://orcid.org/0009-0001-0216-0724)
- Yue Wang (ORCID: https://orcid.org/0000-0002-4501-8699)
Institutions
- Tianjin University of Science and Technology (CN)
- Qilu University of Technology (CN)
Publication Details
- Journal
- Translational Cancer Research
- Published
- 2024-09-23
- DOI
- https://doi.org/10.21037/tcr-24-258
- Citations
- 3
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.26
Funders
- National Science Foundation